← Back to Patent Explorer
US4920962A Expired / Lapsed US ⏱️ 0.0 years remaining

Splint-like element for use in end-to-end nerve suture

Assignee: Individual
•
Filing: 1988-11-23
•
Granted: 1990-05-01
•
Expires: 2008-11-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed is a splint-like element for use in end-to-end nerve suture to eliminate tension at the anastomosis site and thus allow optimal coaptation between the nerve ends to be sutured. The element comprises an elongated body made of a material that is rigid and slightly resilient and is biologically acceptable, such as silicone. The body is long enough to have one end attachable to the epineurium of one of the nerve ends by at least one but preferably two longitudinally spaced-apart sutures, and another end attachable to the epineurium of the other nerve end also by at least one but preferably two other longitudinally spaced-apart sutures. The element also comprises pieces of reinforcing material preferably consisting of beads of plastic material embedded into the body material wherever this body is intended to be attached to the epineurium to prevent the body material from being torn or otherwise cut by the sutures. In use, two such splint-like elements may be attached symmetrically to the epineurium of the nerve ends while the same are held into contact in order to make the suture site tension free. Then, the nerve ends may be sutured as is known in the medical art to achieve the requested anastomosis.

Inventors

  • 👤 Claude Proulx

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:03
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/11; A61B17/1128

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 157 words
A stent element for use in end-to-end nerve suture to eliminate tension between the nerve ends at an anastomosis site and thus allow optimal coaptation between said ends, said stent element comprising an elongated body made of a material that is slightly resilient and is biologically acceptable, said elongated body being long enough to have one end attachable to an epineurium of one of said nerve ends at a first given distance from the anastomosis site by at least one suture, and another end of said elongated body attachable to the epineurium of the other of said nerve ends at a second given distance from the anastomosis site by at least one other suture, said stent element further including pieces of reinforcing material consisting of beads of plastic material embedded into said slightly resilient material of said elongated body and disposed so as to prevent said elongated body from being torn or otherwise cut by said sutures.
Claim 2
Dependent Claim 157 words
A stent element for use in end-to-end nerve suture to eliminate tension between the nerve ends at an anastomosis site and thus allow optimal coaptation between said ends, said stent element comprising an elongated body made of a material that is slightly resilient and is biologically acceptable, said elongated body being long enough to have one end attachable to an epineurium of one of said nerve ends at a first given distance from the anastomosis site by at least one suture, and another end of said elongated body attachable to the epineurium of the other of said nerve ends at a second given distance from the anastomosis site by at least one other suture, said stent element further including pieces of reinforcing material consisting of beads of plastic material embedded into said slightly resilient material of said elongated body and disposed so as to prevent said elongated body from being torn or otherwise cut by said sutures.
Claim 3
Dependent Claim 55 words
The element of claim 1, wherein each of the ends of said elongated body comprises at least two beads of plastic material that are embedded into the slightly resilient material and longitudinally spaced apart to allow said body end to be attached to the epineurium of said nerve ends each by at least two sutures.
Claim 4
Dependent Claim 14 words
The element of claim 2, wherein said slightly resilient material is a silicone resin.
Claim 5
Dependent Claim 20 words
The element of claim 2, wherein said slightly resilient material consists of SILASTIC® and said plastic material consists of DACRON®.
Claim 6
Independent Claim 246 words
A method of carrying out end-to-end nerve suture in order to achieve maximum coaptation between the nerve ends at the anastomosis site using stent elements provided with an elongated body made of a material that is slightly resilient and biologically acceptable, said method comprising the steps of: attaching by means of at least one suture, one end of a first stent element to one side of the epineurium of one of said nerve ends to be sutured at a given distance from the anastomosis site in such a manner that the other end of said first element projects away from said one nerve end; attaching by means of at least one other suture, the one end of a second stent element to the epineurium of said one nerve end at the same given distance from the anastomosis site in such a manner that said second element extends parallel to the first element on the opposite side of said one nerve end; pulling the other of said nerve ends in between the other ends of said first and second stent elements to such an extent that said other nerve end be at least in contact with said one nerve end; attaching each of said other ends of said first and second elements to the epineurium of said other nerve end by means of at least one further suture, thereby making the nerve suture site tension-free; and then suturing together both of said nerve ends to achieve anastomosis.
Claim 7
Independent Claim 246 words
A method of carrying out end-to-end nerve suture in order to achieve maximum coaptation between the nerve ends at the anastomosis site using stent elements provided with an elongated body made of a material that is slightly resilient and biologically acceptable, said method comprising the steps of: attaching by means of at least one suture, one end of a first stent element to one side of the epineurium of one of said nerve ends to be sutured at a given distance from the anastomosis site in such a manner that the other end of said first element projects away from said one nerve end; attaching by means of at least one other suture, the one end of a second stent element to the epineurium of said one nerve end at the same given distance from the anastomosis site in such a manner that said second element extends parallel to the first element on the opposite side of said one nerve end; pulling the other of said nerve ends in between the other ends of said first and second stent elements to such an extent that said other nerve end be at least in contact with said one nerve end; attaching each of said other ends of said first and second elements to the epineurium of said other nerve end by means of at least one further suture, thereby making the nerve suture site tension-free; and then suturing together both of said nerve ends to achieve anastomosis.
Claim 8
Dependent Claim 40 words
The method of claim 5, wherein said first and second stent elements further include beads of plastic material embedded into the elongated bodies as pieces of reinforcing material, to prevent said bodies from being torn or cut by the sutures.
Claim 9
Dependent Claim 50 words
The method of claim 5, wherein said first and second stent element further include at least two beads of plastic material embedded into each of their body ends, and wherein each of said body ends is attached to the epineurium of the corresponding nerve end by at least two sutures.
Claim 10
Dependent Claim 50 words
The method of claim 7 wherein said first and second stent element further include at least two beads of plastic material embedded into each of their body ends, and wherein each of said body ends is attached to the epineurium of the corresponding nerve end by at least two sutures.
Claim 11
Dependent Claim 33 words
The method of claim 7, wherein use is made of a 5-0 nylon suture wire to attach said first and second stent elements to said one nerve end and said other nerve end.
Claim 12
Dependent Claim 33 words
The method of claim 7, wherein use is made of a 6-0 nylon suture wire to attach said first and second stent elements to said one nerve end and said other nerve end.
Claim 13
Dependent Claim 34 words
The method of claim 5, wherein said nerve end is pulled in-between said first and second stent elements to such an extent that said other nerve end extends slightly over said one nerve end.
Claim 14
Dependent Claim 40 words
The method of claim 11, wherein said first and second stent elements further include beads of plastic material embedded into the elongated bodies as pieces of reinforcing material to prevent said bodies from being torn or cut by the sutures.
Claim 15
Dependent Claim 50 words
The method of claim 12, wherein said first and second stent element further include at least two beads of plastic material embedded into each of their body ends, and wherein each of said body ends is attached to the epineurium of the corresponding nerve end by at least two sutures.
Claim 16
Dependent Claim 40 words
The method of claim 11, comprising the additional step of resecting at least one of said nerve ends to adjust its length and shape to fit the other of said nerve ends prior to suturing both of said nerve ends.
Claim 17
Dependent Claim 40 words
The method of claim 14, wherein said first and second stent elements further include beads of plastic material embedded into the elongated bodies as pieces of reinforcing material to prevent said bodies from being torn or cut by the sutures.
Claim 18
Dependent Claim 33 words
The method of claim 5, wherein use is made of a 5-0 nylon suture wire to attach said first and second stent elements to said one nerve end and said other nerve end.
Claim 19
Dependent Claim 33 words
The method of claim 5, wherein use is made of a 6-0 nylon suture wire to attach said first and second stent elements to said one nerve end and said other nerve end.

References Cited (Backward Citations)

US4632113A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-04-30 1993-10-30 1994-05-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-04-30 1997-10-30 1998-05-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-04-30 2001-10-30 2002-05-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag